Rigel Pharmaceuticals Inc (NASDAQ: RIGL) stock enjoyed a major increase of 16.0% on 1/17/25. The shares closed at $20.13. Moreover, trading volume in this advance was unusually high at 197% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 23.9% during the last week.
Current PriceTarget Research Rating
Rigel Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment